Search

Search results

1. Canadian patients suffer lack of access to cancer drugs

   New research by scholars at the University of Pittsburgh shows how bad access to new cancer medicines is in Canada, especially compared to the United States: Of 45 anticancer drug indications approved in the United States between January ...

2. Trump pharmaceutical policy may help raise Canadian drug prices to American levels

   A statement from Donald Trump’s health reform proposal poses a potential problem for Canadians: Remove barriers to entry into free markets for drug providers that offer safe, reliable and cheaper products. Congress will need the courage ...

3. U.S. should follow Canada’s lead on EpiPens

   If you follow the health reform debate in the United States, you know that every once in a while a pharmaceutical executive decides to poke the political dragon by jacking up the price of a prescription drug. This time around, it is ...

4. A Lethal Guardian: The Canadian Government's Ban on Prescription Drugs

   When any new drug is invented and ready for distribution in Canada, the Canadian government responds by enforcing an automatic ban on its use. This ban is removed for patients who need the drug immediately only under extraordinary circumstances. The ...

5. Canadian Pharmacare: Performance, Incentives, and Insurance

   This paper discusses differences between provincial drug plans with respect to breadth of coverage and cost sharing between patients and taxpayers, and introduces two new measurements to describe how provincial Pharmacare plans perform as insurers and how ...

6. Advertising Prescription Drugs Benefits American Patients

     One difference between Canadian and American health care is that the US government allows research-based drug makers to advertise the benefits of their medicines to patients, but the Canadian government outlaws this freedom of speech. Unfortunately, the ...

7. Ban Online Pharmacies

   Appeared in the Winnipeg Free Press The government of Manitoba has embarked on an ill-advised industrial policy that will not only put Canadians’ health at risk without improving employment or economic growth in the province, but also violates the ...

8. Prescription Drug Prices in Canada and the United States, Part 4: Canadian Prescriptions for American Patients Are Not the Solution

   This paper looks at the cross-border mail-order pharmaceutical trade and determines that it suffers serious flaws. https://www.fraserinstitute.org/sites/default/files/CanadianPrescriptionsforAmericans.pdf ...

9. Advertising Prescription Drugs Will Benefit Canadians

   Appeared in the Sentinel-Review According to the Canadian Medical Association Journal, our government should continue to prohibit research-based drug makers from communicating with patients through direct-to-consumer advertising (DTCA). A survey reported ...

10. Briefing to the House of Commons Standing Committee on Health on Prescription Drugs

    The Canadian government needs to abolish pharmaceutical price controls, increase competition amongst drug makers by allowing advertising, stop the gray market in prescription drugs from Canada to the United States, and take other steps to improve ...